Answers are grounded in this paper and cite their sources.
Botulinum toxin A is commonly used to reduce spasticity and dystonia in children with cerebral palsy. We report a pediatric patient who developed systemic botulism as a result of a severe overdose of the injected toxin (40 U/kg). This case highlights the importance of physicians having adequate knowledge of primate and human literature on the lethal dose, 50% of botulinum toxin A before injecting children.
No takes yet. Share an insight, caveat, or question.
Crowner et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: